Current Ratio of ImmunoGen, Inc. from 31 Mar 2012 to 30 Sep 2023
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
ImmunoGen, Inc. quarterly Current Ratio in x history and change rate from 31 Mar 2012 to 30 Sep 2023.
- ImmunoGen, Inc. Current Ratio for the quarter ending 30 Sep 2023 was 4.39x, a 1.8% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
ImmunoGen, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q3 2023 | 4.39x | -0.08x | -1.8% | 30 Sep 2023 |
| Q2 2023 | 3.68x | -0.55x | -13% | 30 Jun 2023 |
| Q1 2023 | 3.07x | -0.53x | -15% | 31 Mar 2023 |
| Q4 2022 | 3.74x | +0.82x | +28% | 31 Dec 2022 |
| Q3 2022 | 4.47x | +2.04x | +84% | 30 Sep 2022 |
| Q2 2022 | 4.22x | +1.84x | +77% | 30 Jun 2022 |
| Q1 2022 | 3.6x | +1.13x | +46% | 31 Mar 2022 |
| Q4 2021 | 2.92x | +0.27x | +10% | 31 Dec 2021 |
| Q3 2021 | 2.43x | -0.23x | -8.5% | 30 Sep 2021 |
| Q2 2021 | 2.39x | -0.38x | -14% | 30 Jun 2021 |
| Q1 2021 | 2.47x | -0.49x | -17% | 31 Mar 2021 |
| Q4 2020 | 2.65x | -0.61x | -19% | 31 Dec 2020 |
| Q3 2020 | 2.66x | -0.91x | -26% | 30 Sep 2020 |
| Q2 2020 | 2.77x | -1.38x | -33% | 30 Jun 2020 |
| Q1 2020 | 2.96x | -1.76x | -37% | 31 Mar 2020 |
| Q4 2019 | 3.26x | -1.22x | -27% | 31 Dec 2019 |
| Q3 2019 | 3.57x | -1.16x | -25% | 30 Sep 2019 |
| Q2 2019 | 4.15x | -0.08x | -1.8% | 30 Jun 2019 |
| Q1 2019 | 4.73x | +1.33x | +39% | 31 Mar 2019 |
| Q4 2018 | 4.48x | +1.17x | +35% | 31 Dec 2018 |
| Q3 2018 | 4.74x | +1.84x | +64% | 30 Sep 2018 |
| Q2 2018 | 4.23x | +1.1x | +35% | 30 Jun 2018 |
| Q1 2018 | 3.39x | -0.27x | -7.3% | 31 Mar 2018 |
| Q4 2017 | 3.32x | -0.59x | -15% | 31 Dec 2017 |
| Q3 2017 | 2.9x | -1.48x | -34% | 30 Sep 2017 |
| Q2 2017 | 3.13x | -2.05x | -40% | 30 Jun 2017 |
| Q1 2017 | 3.66x | -2.62x | -42% | 31 Mar 2017 |
| Q4 2016 | 3.91x | -2.61x | -40% | 31 Dec 2016 |
| Q3 2016 | 4.38x | -2.58x | -37% | 30 Sep 2016 |
| Q2 2016 | 5.17x | -0.41x | -7.4% | 30 Jun 2016 |
| Q1 2016 | 6.28x | +1.33x | +27% | 31 Mar 2016 |
| Q4 2015 | 6.52x | +0.97x | +17% | 31 Dec 2015 |
| Q3 2015 | 6.96x | +0.54x | +8.4% | 30 Sep 2015 |
| Q2 2015 | 5.59x | -3.55x | -39% | 30 Jun 2015 |
| Q1 2015 | 4.95x | -5.11x | -51% | 31 Mar 2015 |
| Q4 2014 | 5.55x | -5.76x | -51% | 31 Dec 2014 |
| Q3 2014 | 6.42x | -5.81x | -48% | 30 Sep 2014 |
| Q2 2014 | 9.14x | -4.07x | -31% | 30 Jun 2014 |
| Q1 2014 | 10.06x | -3.21x | -24% | 31 Mar 2014 |
| Q4 2013 | 11.31x | -1.85x | -14% | 31 Dec 2013 |
| Q3 2013 | 12.23x | -1.21x | -9% | 30 Sep 2013 |
| Q2 2013 | 13.21x | +0.23x | +1.8% | 30 Jun 2013 |
| Q1 2013 | 13.27x | -0.76x | -5.4% | 31 Mar 2013 |
| Q4 2012 | 13.16x | 31 Dec 2012 | ||
| Q3 2012 | 13.43x | 30 Sep 2012 | ||
| Q2 2012 | 12.98x | 30 Jun 2012 | ||
| Q1 2012 | 14.03x | 31 Mar 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.